GW&K Investment Management LLC Acquires 11,093 Shares of U.S. Physical Therapy, Inc. $USPH

GW&K Investment Management LLC lifted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 3.2% in the 4th quarter, Holdings Channel reports. The institutional investor owned 361,974 shares of the company’s stock after purchasing an additional 11,093 shares during the quarter. GW&K Investment Management LLC’s holdings in U.S. Physical Therapy were worth $28,267,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of USPH. Royal Bank of Canada boosted its position in shares of U.S. Physical Therapy by 3.4% during the first quarter. Royal Bank of Canada now owns 79,238 shares of the company’s stock worth $5,733,000 after buying an additional 2,594 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of U.S. Physical Therapy by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company’s stock worth $644,000 after buying an additional 391 shares during the period. Jane Street Group LLC boosted its position in shares of U.S. Physical Therapy by 249.3% during the first quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock worth $3,568,000 after buying an additional 35,191 shares during the period. Hsbc Holdings PLC acquired a new position in shares of U.S. Physical Therapy during the second quarter worth about $410,000. Finally, First Trust Advisors LP boosted its position in shares of U.S. Physical Therapy by 3.7% during the second quarter. First Trust Advisors LP now owns 10,725 shares of the company’s stock worth $839,000 after buying an additional 385 shares during the period.

Insider Buying and Selling

In other U.S. Physical Therapy news, Director Peter Francis Minan acquired 492 shares of the business’s stock in a transaction dated Monday, June 8th. The stock was bought at an average cost of $63.14 per share, with a total value of $31,064.88. Following the completion of the transaction, the director directly owned 2,923 shares in the company, valued at approximately $184,558.22. This represents a 20.24% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 2.40% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on USPH shares. Citizens Jmp reduced their price objective on U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating for the company in a research report on Friday, May 8th. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Citigroup reaffirmed an “outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, May 8th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Friday, May 29th. Finally, Jefferies Financial Group raised U.S. Physical Therapy to a “strong-buy” rating in a research report on Thursday, March 12th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, U.S. Physical Therapy has an average rating of “Moderate Buy” and a consensus target price of $97.50.

U.S. Physical Therapy Stock Performance

Shares of NYSE USPH opened at $62.92 on Thursday. The stock has a 50 day moving average price of $68.57 and a 200 day moving average price of $76.38. U.S. Physical Therapy, Inc. has a 52 week low of $58.19 and a 52 week high of $93.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.19 and a current ratio of 1.19. The stock has a market capitalization of $957.56 million, a PE ratio of 125.84, a price-to-earnings-growth ratio of 1.71 and a beta of 1.16.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.09). U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The company had revenue of $198.29 million for the quarter, compared to analyst estimates of $200.94 million. During the same period last year, the company posted $0.48 earnings per share. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. Analysts predict that U.S. Physical Therapy, Inc. will post 2.99 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 22nd will be given a dividend of $0.46 per share. The ex-dividend date of this dividend is Friday, May 22nd. This represents a $1.84 annualized dividend and a yield of 2.9%. U.S. Physical Therapy’s dividend payout ratio is 368.00%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.